Add to Chrome
✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
What is one of the key causes leading to the slow development of miRNA-based therapeutics?
Serious immune-related adverse effects in most clinical trials
Insufficient funding
Lack of clinical trial data
each miRNA has too many targets, increasing aspecific effects
Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!